Ecdystene clinical trials
Also written BIO101 and ecdysterone.
How each study uses ecdystene is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 2
Biophytis (2) · Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan (1) · University of Guadalajara (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test ecdystene, phase 3 first.
- Dec 2026Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysonePhase 2/3 · Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
Studies
Open first, then newest update. How each study uses ecdystene is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Efficacy and Safety of BIO101 in the Prevention of Respiratory Deterioration in Hospitalized COVID-19 PatientsTerminatedPhase 2/3BiophytisNCT04472728Written as BIO101
- Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysoneActive, not recruitingPhase 2/3Research Institute of Epidemiology, Microbiology and Infectious Diseases, UzbekistanNCT04827537Written as 20-hydroxyecdysone Oral
- A Double-blind, Placebo-controlled, Randomized INTerventional Clinical Trial (SARA-INT)CompletedPhase 2BiophytisNCT03452488Written as BIO101
- Effect of Phytoecdysterone Administration in Subjects With PrediabetesStatus unknownNot applicableUniversity of GuadalajaraNCT03906201Written as Ecdysterone
Given beside what is tested · 1 — ecdystene is usual care or a partner of the new treatment
Codes
What other systems call ecdystene · ClinicalTrials.gg INT003797
- MeSH (NLM) C088647ecdysteneOne source NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C088647 | ecdystene | One source NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.